Skip to main content
Fig. 3 | BMC Clinical Pathology

Fig. 3

From: Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer

Fig. 3

Kaplan-Meier survival analysis for MCT1 expression using unadjusted and grade stratified models. Recurrence-free, cancer specific and overall survival is shown for unadjusted model in (a, b and c); in grade III tumours (from grade stratified model) only (d, e and f), respectively. High MCT1 expression significantly reduced overall survival in c unadjusted and f in grade III tumours. The events for each arm are shown in insets (event/total, %)

Back to article page
\